Trials / Completed
CompletedNCT01729182
Nexium Capsules LDA Specific Clinical Experience Investigation
Nexium Capsules Specific Clinical Experience Investigation for Long-term Use Concerning Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer With LDA
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,363 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastric ulcer or duodenal ulcer with Low dose Aspirin (LDA).
Detailed description
Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with Low dose Aspirin (LDA).
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2017-03-09
- Completion
- 2017-03-09
- First posted
- 2012-11-20
- Last updated
- 2019-08-07
Locations
47 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01729182. Inclusion in this directory is not an endorsement.